Vioxx &quot;Scandal&quot; Opens Door To Drug Safety Pandora&#39;s Box
615822
When Merck&#39;s arthritis drug Vioxx was withdrawn from the market in September, concerns over drug safety were pretty much under the radar for the most part, but not today.
256630
Nov. 11, 2004 -- A private research team claims to have identified a unique action of the painkiller Vioxx, which is independent of its anti-inflammatory action, that might explain why it&#39;s linked to heart
161932
The problems with Vioxx, taken off the market last week, raise questions about the Food and Drug Administration's safety review process. Observers say longer clinical trials should be required.
167999
U.S. drug safety regulators are  coming under fire for their response to years of suspicions,  confirmed last week, that arthritis drug Vioxx increased the  risks of heart attacks and strokes.
476114
WASHINGTON - The FDA scientist who studied the safety of the recalled painkiller Vioxx delivered a bombshell Thursday, naming five more drugs he believes could be dangerous.
545492
Is the US Food &amp; Drug Administration failing? That was the testimony of one senior FDA official last week concerning Merck&#39;s withdrawal of the Vioxx anti-pain drug.
596017
The nation&#39;s system for ensuring that drugs are safe faces perhaps its biggest crisis in years, with the disclosures that federal regulators and drug giant Merck allowed Vioxx
704207
Those on Vioxx were 2.7 times likelier to have a problem, but an expert questions the safety of the entire class of painkillers. By Amanda Gardner.
353822
Momentum was growing for a fresh look at the safety of Celebrex and other pain relievers as key researchers, a congressman and European regulators said they feared such drugs might raise the risk of heart problems like those blamed on the arthritis medicine Vioxx.    Heavily advertised as an arthritis drug, Vioxx was pulled from the market last week after its maker said a study showed it doubled the risk of heart attack and stroke...
303984
At least five medications now sold to consumers pose such risks that their sale should be limited or stopped, said a government drug reviewer who raised safety questions earlier about the arthritis drug Vioxx.
592422
It&#39;s amazing how much we&#39;re learning these days about what the FDA knew in years past. Considering what the agency suppressed about Vioxx, antidepressant drugs, and flu vaccine contamination, I&#39;m starting
469011
Britain is to overhaul and open up its  drug safety monitoring system, already viewed as one of the  better schemes worldwide, in the wake of recent scandals over  the side effects of some medicines.  Patients will in future be able to view anonymous data on  suspected adverse drug reactions on the Medicines and  Healthcare Products Regulatory Agency's (MHRA) Web site, Health  Minister Lord Warner said Monday.
513761
The U.S. Food and Drug Administration on Friday asked an outside group to review the way it monitors safety risks associated with medicines already on the market, such as Merck & Co. Inc.'s withdrawn painkiller Vioxx.
119747
Americans should feel reasonably safe taking government-approved prescription drugs - with a few caveats - even after a popular arthritis medication was pulled from the market, medical experts say. But the problems with Vioxx raise questions about the Food and Drug Administration's safety review process and the length of time it took Merck to pull the drug, observers say...
62492
Merck&#39;s recall of its arthritis pain drug, Vioxx, because of elevated risks of heart attack and stroke has obscured another important issue that Congress, in investigating the matter, must face squarely and deal with: What happens when pharmaceutical
422988
The withdrawal of Vioxx from the market in September and more recent concerns about its cousin Bextra have raised safety questions about this entire class of painkillers
134259
&quot;We were wrong about Vioxx, but you can trust us on all those other meds,&quot; the FDA seems to be saying. If you enjoy this article, you may also be interested in an article entitled &#39;The FDA remains in state of denial about drug safety questions.